BioSpace News Archive

Continues progress toward antitrust clearance for Bayer AG’s animal health business

Phitonex, Inc., developers of next generation fluorescent labels for biomarker detection, is pushing the envelope of what is possible in flow cytometry and today publicly shared the first data set showing 40 colors measured simultaneously on single cells in an experiment.

INTELLiSTEM Technologies Inc., a biotechnology company pioneering cellular vaccines and peptide therapeutics, announced the successful development of a peptide-based vaccine candidate (IPT-001) intended for human use against COVID-19.

The Clinical Research Forum, along with the Clinical Research Foundation, has announced it will broadcast its annual Top Ten Clinical Research Achievement Awards ceremony virtually this year, and will be available to view on Wednesday, April 15 at 11 a.m. Eastern Time.

Leading Remote Trial Management and Risk-Based Monitoring Organization to Use eISF, eTMF, and LMS Solutions

Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, continues to operate and supply product to the medical community through the global coronavirus crisis and has been preparing for the anticipated surge in demand for surgical procedures when normal operations resume.

Institute for Supply Management® study second wave details virus’ adverse effects

Covers Allow for Reuse of Critical Supply of Masks - Thousands of Mask Covers to Be Made [14-April-2020] ROBBINSDALE , Minn. and EAGAN, Minn. , April 14, 2020 /PRNewswire/ -- As the number of COVID-19 cases continues to rise in Minnesota , healthcare organizations have a pressing need to protect their critical supplies of personal protective equipment (PPE), includi

Pharmefex, Sync.MD and X-CELLSYSTEM, all U.S. companies based in the state of Washington, have formed an alliance to provide an urgently needed resource for our nation’s ability to Open Our Country.

Celavie Biosciences, LLC, a company working to improve lives and restore hope by advancing innovations in CNS diseases with regenerative stem cell-based therapies, today announced that the Company will give a corporate presentation at the April 2020 Virtual Investor Summit, taking place online from April 22-23, 2020.